Status:
TERMINATED
Optimization of SPECT Imaging
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Single Photon Emission Computed Tomography (SPECT) is a 3D nuclear medicine imaging technique that is used extensively to study the heart and diagnose heart disease. There are three major limitations ...
Eligibility Criteria
Inclusion
- Intermediate to high risk patients with coronary artery disease who are scheduled for routine SPECT or PET perfusion imaging
Exclusion
- Pregnancy and breast feeding
- Severe narrowing (stenosis) of the aortic valve
- Severe heart failure
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01519973
Start Date
August 1 2008
End Date
August 1 2012
Last Update
April 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y 4W7